KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Emergent BioSolutions (EBS) Non-cash Items (2016 - 2018)

Emergent BioSolutions has reported Non-cash Items over the past 8 years, most recently at $32.8 million for Q4 2018.

For Q4 2018, Non-cash Items fell 26.29% year-over-year to $32.8 million; the TTM value through Dec 2018 reached $32.8 million, down 26.29%, while the annual FY2018 figure was $32.8 million, 26.29% down from the prior year.
Non-cash Items for Q4 2018 was $32.8 million at Emergent BioSolutions, down from $44.5 million in the prior quarter.
Over five years, Non-cash Items peaked at $52.1 million in Q4 2015 and troughed at $53156.0 in Q1 2014.
A 5-year average of $22.2 million and a median of $22.9 million in 2015 define the central range for Non-cash Items.
On a YoY basis, Non-cash Items climbed as much as 26782.05% in 2014 and fell as far as 98.13% in 2014.
Year by year, Non-cash Items stood at $29.2 million in 2014, then surged by 78.6% to $52.1 million in 2015, then plummeted by 51.37% to $25.3 million in 2016, then surged by 75.55% to $44.5 million in 2017, then fell by 26.29% to $32.8 million in 2018.
Business Quant data shows Non-cash Items for EBS at $32.8 million in Q4 2018, $44.5 million in Q4 2017, and $38.0 million in Q3 2017.